Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Of course it comes down to

Of course it comes down to

posted on May 07, 2008 09:01AM
structure and cost as it would for ANY M/A so why would it, necessarily, be considered a bad thing to merge with TPL? While it is certainly speculation...why is it being called FUD? Shouldn't the BOD be looking at all possibilities for M/A and what is best for shareholders? I hope so.
Share
New Message
Please login to post a reply